Certainly I'll say from Genome Canada's perspective that the researchers as individuals are used to collaborating internationally. What we're seeing now is a more systematic approach to this and we're having a lot of international tools. For instance, there is something called the Global Alliance for Genomics and Health, which serves to have set standards and share best practices. Its secretariat is actually based here in Canada but it is operating internationally. They do a lot of coordination work to support that on-the-ground collaboration.
Then we've had a number of companies, data companies in particular but also other biotech companies, reaching out to us just to offer to help and not for their own personal intellectual property development but to offer their services. I think we're certainly seeing a motivation like we haven't seen before.